|
DE144266C
(enExample)
|
|
|
|
|
|
US3138588A
(en)
|
1962-08-24 |
1964-06-23 |
American Home Prod |
17-ketals of estrone and derivatives thereof
|
|
US3177206A
(en)
|
1963-03-07 |
1965-04-06 |
American Home Prod |
Selective bromination of a-ring aromatic 17-ketalized steroids
|
|
US3433785A
(en)
|
1966-07-11 |
1969-03-18 |
Sterling Drug Inc |
15,16-disubstituted aromatic steroids,intermediates and processes
|
|
US3673180A
(en)
|
1970-06-18 |
1972-06-27 |
Merck & Co Inc |
19-nor-6,6-ethylene-20-spiroxenes
|
|
US4792620A
(en)
|
1983-10-14 |
1988-12-20 |
Bp Chemicals Limited |
Carbonylation catalysts
|
|
US4739078A
(en)
|
1984-02-17 |
1988-04-19 |
The Upjohn Company |
Use of borohydride-salt lanthanide salt reagents for stereo selective reduction of C-15-keto prostaglandin precursors
|
|
IE60780B1
(en)
|
1987-01-23 |
1994-08-10 |
Akzo Nv |
New 11-aryl steroid derivatives
|
|
DE3710728A1
(de)
|
1987-03-31 |
1988-10-13 |
Schering Ag |
Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
|
|
US5073374A
(en)
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
|
US5340586A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
|
JPH07101977A
(ja)
|
1993-10-05 |
1995-04-18 |
Kureha Chem Ind Co Ltd |
ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
|
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
|
US6117446A
(en)
|
1999-01-26 |
2000-09-12 |
Place; Virgil A. |
Drug dosage unit for buccal administration of steroidal active agents
|
|
TW548277B
(en)
|
1999-07-16 |
2003-08-21 |
Akzo Nobel Nv |
Orally active androgens
|
|
US20020132801A1
(en)
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
|
EP1260225A1
(en)
|
2001-05-18 |
2002-11-27 |
Pantarhei Bioscience B.V. |
A pharmaceutical composition for use in hormone replacement therapy
|
|
PT1390040E
(pt)
|
2001-05-18 |
2007-04-30 |
Pantarhei Bioscience Bv |
Composição farmacêutica para ser utilizado na terapia hormonal de substituição.
|
|
EP1390042B1
(en)
|
2001-05-23 |
2007-11-28 |
Pantarhei Bioscience B.V. |
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
|
|
ES2337129T3
(es)
|
2001-05-23 |
2010-04-21 |
Pantarhei Bioscience B.V. |
Sistema de administracion de medicamento comprendiendo un estrogeno tetrahidroxilado para el uso en la anticoncepcion hormonal.
|
|
WO2003018026A1
(en)
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
US8026228B2
(en)
|
2001-11-15 |
2011-09-27 |
Pantarhei Bioscience B.V. |
Estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
US6723348B2
(en)
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
|
HU227198B1
(en)
|
2001-11-27 |
2010-10-28 |
Richter Gedeon Nyrt |
Pharmaceutical composition for emergency contraception containing levonorgestrel
|
|
DE60215224T2
(de)
|
2002-02-21 |
2007-08-23 |
Schering Aktiengesellschaft |
Pharmazeutische zusammensetzung, enthaltend ein oder mehrere steroide, eine oder mehrere tetrahydrofolatverbindungen und vitamin b12
|
|
US20050147670A1
(en)
|
2002-05-29 |
2005-07-07 |
Impax Laboratories Inc. |
Oral disintegrating dosage forms
|
|
CN100352445C
(zh)
|
2002-06-11 |
2007-12-05 |
潘塔希生物科学股份有限公司 |
一种皮肤护理组合物及其用途
|
|
PT1511496E
(pt)
|
2002-06-11 |
2007-01-31 |
Pantarhei Bioscience Bv |
Método para tratamento ou prevenção de doenças mediadas pelo sistema imunitário e formulação farmacológica para utilização nas mesmas
|
|
SI1526856T1
(sl)
|
2002-07-12 |
2008-04-30 |
Pantarhei Bioscience Bv |
Farmacevtski sestavek, ki obsega estetrolne derivate za uporabo pri zdravljenju raka
|
|
SI1556058T1
(sl)
|
2002-10-23 |
2008-02-29 |
Pantarhei Bioscience Bv |
Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka
|
|
AU2003279624A1
(en)
|
2002-11-08 |
2004-06-07 |
Pantarhei Bioscience B.V. |
Synthesis of estetrol via estrone derived steroids
|
|
SI1624878T1
(sl)
|
2003-05-22 |
2007-02-28 |
Pantarhei Bioscience Bv |
Uporaba sestavkov, ki obsegajo estrogensko komponento, za zdravljenje in preprecevanje muskuloskeletne bolecine
|
|
CN101189251B
(zh)
|
2005-05-26 |
2012-09-12 |
索尔瓦药物有限公司 |
17β-HSD1和STS抑制剂
|
|
EP1910528A2
(de)
|
2005-07-25 |
2008-04-16 |
Technische Universität Dresden |
Rna-abhängige rna-polymerase, verfahren und kits zur amplifikation und / oder markierung von rna
|
|
US20070048369A1
(en)
|
2005-08-26 |
2007-03-01 |
National Starch And Chemical Investment Holding Corporation |
Mucosal delivery tablet
|
|
WO2007081206A1
(en)
|
2006-01-09 |
2007-07-19 |
Pantarhei Bioscience B.V. |
A method of treating an acute vascular disorder
|
|
US20080113953A1
(en)
|
2006-06-08 |
2008-05-15 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
US20070286819A1
(en)
|
2006-06-08 |
2007-12-13 |
Warner Chilcott Company, Inc. |
Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
SG174785A1
(en)
|
2006-06-08 |
2011-10-28 |
Warner Chilcott Co Llc |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty
|
|
GB0621926D0
(en)
|
2006-11-03 |
2006-12-13 |
Medlock Medical Ltd |
Multi directional stretch tubular bandages
|
|
TW200831139A
(en)
|
2006-11-29 |
2008-08-01 |
Wyeth Corp |
Estrogen/SERM and estrogen/progestin bi-layer tablets
|
|
WO2008079245A2
(en)
|
2006-12-20 |
2008-07-03 |
Duramed Pharmaceuticals, Inc. |
Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
|
|
ATE473746T1
(de)
|
2007-01-08 |
2010-07-15 |
Pantarhei Bioscience Bv |
Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens
|
|
CN101631536A
(zh)
|
2007-01-12 |
2010-01-20 |
惠氏公司 |
片中片组合物
|
|
EP2155205B1
(en)
|
2007-06-21 |
2011-12-21 |
Pantarhei Bioscience B.V. |
Treatment of meconium aspiration syndrome with estrogens
|
|
WO2009011576A1
(en)
|
2007-07-19 |
2009-01-22 |
Pantarhei Bioscience B.V. |
Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
|
|
JPWO2009028676A1
(ja)
|
2007-08-31 |
2010-12-02 |
国立大学法人名古屋大学 |
カルボニル化合物の製造方法およびカルボニル化合物の製造に用いる酸化促進剤
|
|
EP2077272A1
(en)
|
2007-12-21 |
2009-07-08 |
Affibody AB |
Polypeptide libraries with a predetermined scaffold
|
|
EP2077273B1
(en)
|
2007-12-31 |
2011-09-14 |
Animal Technology Institute Taiwan |
Methods for separating casein from soluble proteins in a composition
|
|
US20110250274A1
(en)
|
2008-09-19 |
2011-10-13 |
Shaked Ze Ev |
Estriol formulations
|
|
DE102009007771B4
(de)
|
2009-02-05 |
2012-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Bukkales Applikationssystem, 17α-Estradiol enthaltend
|
|
CN102058604A
(zh)
|
2009-11-17 |
2011-05-18 |
北京万全阳光医学技术有限公司 |
一种含有地诺孕素和戊酸雌二醇的药物组合物及其制备方法
|
|
US9603860B2
(en)
|
2010-07-28 |
2017-03-28 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
|
PT2714712T
(pt)
|
2011-06-01 |
2016-11-08 |
Estetra Sprl |
Processo para a produção de intermediários de estetrol
|
|
SG195118A1
(en)
|
2011-06-01 |
2013-12-30 |
Estetra S A |
Process for the production of estetrol intermediates
|
|
EP2383279A1
(en)
*
|
2011-07-19 |
2011-11-02 |
Pantarhei Bioscience B.V. |
Process for the preparation of estetrol
|
|
WO2013012326A1
(en)
|
2011-07-19 |
2013-01-24 |
Pantarhei Bioscience B.V. |
Tablet containing dehydroepiandrosterone (dhea)
|
|
PL2741824T3
(pl)
|
2011-08-11 |
2018-03-30 |
Estetra S.P.R.L. |
Zastosowanie estetrolu jako środka antykoncepcji awaryjnej
|
|
RU2633640C2
(ru)
|
2011-09-16 |
2017-10-16 |
Ферринг Б.В. |
Быстрорастворимая фармацевтическая композиция
|
|
RS55231B1
(sr)
|
2011-10-07 |
2017-02-28 |
Estetra Sprl |
Postupak proizvodnje estetrola
|
|
EP2653163A1
(en)
|
2012-04-19 |
2013-10-23 |
Université de Liège |
Estrogenic components for use in the treatment of neurological disorders
|
|
US9808470B2
(en)
|
2012-04-19 |
2017-11-07 |
Universite De Liege |
Estrogenic components for use in the treatment of neurological disorders
|
|
WO2014159377A1
(en)
|
2013-03-14 |
2014-10-02 |
Teva Women's Health, Inc. |
Compositions containing tanaproget and natural estrogens
|
|
EP3046928B1
(en)
|
2013-09-18 |
2017-02-08 |
Crystal Pharma, S.A.U. |
Process for the preparation of estetrol
|
|
JP6447931B2
(ja)
|
2013-12-12 |
2019-01-09 |
ドネスタ バイオサイエンス ビー．ブイ．Ｄｏｎｅｓｔａ Ｂｉｏｓｃｉｅｎｃｅ Ｂ．Ｖ． |
エステトロール成分を含有する口腔内崩壊固体単位剤形
|
|
LT3310346T
(lt)
|
2015-06-18 |
2021-06-10 |
Estetra Sprl |
Burnoje disperguojama tabletė, turinti estetrolio
|
|
LT3310345T
(lt)
|
2015-06-18 |
2021-06-25 |
Estetra Sprl |
Burnoje disperguojama tabletė, turinti estetrolio
|
|
DK3701944T3
(da)
|
2015-06-18 |
2022-03-14 |
Estetra Srl |
Oro-dispergerbar doseringsenhed indeholdende en estetrolkomponent
|
|
CR20180042A
(es)
|
2015-06-18 |
2018-05-03 |
Mithra Pharmaceuticals S A |
Unidad de dosificación orodispersable que contiene un componente estetrol.
|